Company intelligence
AIM at Melanoma Foundation
AIM at Melanoma raises awareness, supports patients & funds research to end melanoma in our lifetime.
About AIM at Melanoma Foundation
Founded in 2004, AIM at Melanoma is a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma. AIM at Melanoma is dedicated to: Innovation in Melanoma Research We believe the cure for melanoma will be found more quickly by bringing together leading global researchers and funding their collaborative work. Our paradigm-shifting global initiatives, including the International Melanoma Tissue Bank Consortium, are poised to reshape the future of melanoma treatment and care. Legislation, Policy & Advocacy We are the respected voice of melanoma across the nation. When drugs are approved, legislation is drafted, and research priorities are set, AIM is at the table, speaking loudly and clearly on behalf of patients and families. We are trusted advisors for government agencies, medical boards, and pharmaceutical companies on critical topics affecting melanoma patients. Education & Support We provide comprehensive, accessible resources for patients, caregivers, and healthcare professionals. Our education efforts span awareness campaigns, webinars, conferences, toolkits, and digital content, designed to empower patients and families to navigate melanoma diagnosis, treatment, and survivorship. Our patient support programs are part of a broader commitment to guidance, community, and connection, serving as models for other cancer foundations.
Verified activity
Signals from AIM at Melanoma Foundation
2 published signals
Presence & Recognition
AIM at Melanoma Foundation hosted a free virtual educational program on brain metastases in melanoma on Thursday, September 24, 2026, featuring experts from MD Anderson Cancer Center.
Reported by AIM at Melanoma Foundation
Presence & Recognition
AIM at Melanoma Foundation hosted the inaugural Women in Melanoma Europe meeting in Lisbon, Portugal, bringing together 16 women oncologists from across Europe.
Reported by AIM at Melanoma Foundation